Haemonetics Corp (HAE) Haemonetics Receives FDA Clearance for NexSys® PCS Plasma Collection System with Persona® PLUS Technology
Haemonetics Corp (NYSE: HAE) FY 2026 Other Release
16 articles, transcripts, and reports
Haemonetics Corp (NYSE: HAE) FY 2026 Other Release
Haemonetics Corp (NYSE: HAE) FY 2026 Corporate Conference
Haemonetics Corp (NYSE: HAE) Q3 2026 Earnings Conference
Haemonetics Corp (NYSE: HAE) Sec Form 8K
Haemonetics Corp (NYSE: HAE) Sec Form 10Q
Haemonetics Corp (NYSE: HAE) Sec Form 8K
Haemonetics Corp (NYSE: HAE) Q2 2025 Earnings Call dated Nov. 07, 2024 Corporate Participants: Olga Guyette — Vice President, Investor Relations and Treasury Christopher Simon…
Haemonetics Corp (NYSE: HAE) Q3 2025 Earnings Call dated Feb. 06, 2025 Corporate Participants: Olga Guyette — Vice President, Investor Relations & Treasury Christopher Simon…
Haemonetics Corp (NYSE: HAE) Q4 2025 Earnings Call dated May. 08, 2025 Corporate Participants: Olga Guyette — Vice President, Investor Relations & Treasury Christopher Simon…
Haemonetics Corp (NYSE: HAE) Q1 2026 Earnings Call dated Aug. 07, 2025 Corporate Participants: Olga Guyette — Senior Director of Investor Relations Christopher Simon —…